Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

Published:2006-09 Issue:9540 Volume:368 Page:991-997
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lin Jiangtao,Zhang Jiansan,Dong Xiaoping,Fang Hanhua,Chen Jiangting,Su Nan,Gao Qiang,Zhang Zhenshan,Liu Yuxuan,Wang Zhihong,Yang Meng,Sun Ruihua,Li Changgui,Lin Su,Ji Mei,Liu Yan,Wang Xu,Wood John,Feng Zijian,Wang Yu,Yin Weidong

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Probable person-to-person transmission of avian influenza A (H5N1);Ungchusak;N Engl J Med,2005

2. Evolution of H5N1 avian influenza viruses in Asia;Emerg Infect Dis,2005

3. Selection of influenza vaccine strains and developing pandemic vaccines;Wood;Vaccine,2002

4. Development and evaluation of influenza pandemic vaccines;Stephenson;Lancet Infect Dis,2006

5. Chinese State Food and Drug Administration (SFDA). Special procedure for drug approval. No 21, 2005.

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pandemic preparedness through vaccine development for avian influenza viruses;Human Vaccines & Immunotherapeutics;2024-05-28

2. Selecting and Using the Appropriate Influenza Vaccine for Each Individual;Viruses;2021-05-24

3. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza;Vaccine;2019-04

4. Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine;Archives of Virology;2019-02-10

5. Development and comparison of two H5N8 influenza A vaccine candidate strains;Archives of Virology;2018-10-05